In-vitro sensitivities and treatment of less common mycobacteria

The Journal of Antimicrobial Chemotherapy
B Watt

Abstract

There are very few new agents available for the treatment of infections due to the less common mycobacteria. There have been very few systematic studies of in-vitro activity and fewer clinical trials. Yet such mycobacteria are an important cause of serious disease and often conventional antimycobacterial agents are unsuitable either because of in-vitro resistance of the pathogen concerned, or toxicity of one of the components of drug regimens. At present, newer macrolides and quinolones offer promise, but there is a need to extend the in-vitro studies already under way of newer agents against Mycobacterium avium and/or Mycobacterium tuberculosis, to the other, less common mycobacteria. The benzoxazinorifampicins, the oxazolidinones and the acridinones may prove to be of clinical value. In addition to more information on the in-vitro activity of newer agents, alone and in combination, based on systematic studies involving larger numbers of mycobacterial strains, we need clearer clinical information to enable therapeutic regimens to be formulated and validated. The British Thoracic Society study is but a first step. There need to be more.

Citations

Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Luis Máiz-Carro, Enrique Navas-Elorza
Dec 31, 2002·Pathologie-biologie·J-N DauendorfferM Dailloux
Jun 7, 2003·International Journal of Antimicrobial Agents·J C Rodriguez DíazG Royo
Mar 18, 1999·Transplant International : Official Journal of the European Society for Organ Transplantation·J J de JongW Weimar
Dec 22, 1999·Antimicrobial Agents and Chemotherapy·R Fernández-RoblasF Soriano
Jan 1, 1997·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·I Chopra, P Brennan
Dec 20, 1999·The Journal of Antimicrobial Chemotherapy·S VacherJ Maugein
Sep 25, 2004·Medicinal Research Reviews·Rama P TripathiVinod K Tiwari
May 23, 2017·Current Treatment Options in Infectious Diseases·Julie V PhilleyEdward D Chan
Jul 6, 2000·Scandinavian Journal of Infectious Diseases·M FroschE Harms

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.